Dr. Gino Tutera Announces New "ZONA" Diet
19 juin 2008 12h15 HE
|
Dr. Gino Tutera
PHOENIX, AZ--(Marketwire - June 19, 2008) - Dr. Gino Tutera, a nationally recognized author
and Arizona-based physician, receives the endorsement of Dr. Barry Sears,
creator of the world renowned...
FDA Grants IND to Samaritan's Novel Plaque Clearing Alzheimer's Drug and Requests Additional Information Be Provided Before Starting Its Proposed Phase I Trial
07 déc. 2006 10h15 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 7, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced that the U.S. Food and Drug Administration (FDA) has completed its...
A Medieval Surgical Pharmacopoeia -- New Book Documents Eight Great Surgeons of the Past and Medieval Medicine
24 oct. 2006 14h51 HE
|
Xlibris
SAN FRANCISCO, Oct. 24, 2006 (PRIMEZONE) -- The subject covered in A Medieval Surgical Pharmacopoeia is the use of medicines by surgeons during the years between 1170 and 1325. This includes treatises...
Actelion/Merck Renin Alliance Achieves Third Milestone
06 juil. 2006 01h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, July 6, 2006 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today that the renin alliance with Merck & Co., Inc. (NYSE:MRK) has achieved its third...
Increased Concentrations of ProtoKinetix's Synthetic AFGP Dramatically Slows Aging Process on Skin Cells
07 sept. 2005 10h49 HE
|
ProtoKinetix, Incorporated
VANCOUVER, British Columbia, Sept. 7, 2005 (PRIMEZONE) -- Results just received clearly confirm that in the presence of ProtoKinetix's (OTCBB:PKTX) synthetic antifreeze glycoprotein (AFGP), the aging...
Molecular Diagnostics, Inc. Announces Investor Conference Call, Hosted By Company President & CEO, Denis M. O'Donnell, M.D.
23 nov. 2004 09h00 HE
|
Molecular Diagnostics, Inc.
CHICAGO, Nov. 23, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG), today announced an investor conference call to be held at 4:15 p.m. Eastern Daylight Savings Time on Wednesday,...
NIDEK -- US Hyperopia Clinical Study Update -- 9-Month Update
22 oct. 2004 14h41 HE
|
NIDEK, Inc.
FREMONT, Calif., Oct. 22, 2004 (PRIMEZONE) -- NIDEK, Inc. today announced, 9-month clinical data from its US FDA Hyperopia Clinical Study for the treatment of hyperopia and hyperopic astigmatism....
Integra Epilepsy(TM) Products Receive CE Mark For Distribution in the European Union
19 oct. 2004 06h00 HE
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, New Jersey, Oct. 19, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it was awarded the CE Mark required for commercial distribution of...
Integra LifeSciences Announces CE Mark for DuraGen Plus(TM) Adhesion Barrier Matrix
18 oct. 2004 06h00 HE
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received CE Mark Certification for the DuraGen Plus(TM) Adhesion...
Integra NeuroSciences Launches NPH(TM) Low Flow Hydrocephalus Valve
15 oct. 2004 06h00 HE
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the NPH(TM) Low Flow Hydrocephalus Valve (NPH(TM)...